EsoCap Biotech
2 known investors
EsoCap is developing a smart drug delivery platform for long-lasting, targeted topical therapy of the esophagus, designed to increase mucosal contact time and drug deposition. Its lead candidate ESO-101 is being developed to treat patients with eosinophilic esophagitis (EoE).
BiotechMedical Devices
Founders & leadership
IR
Isabelle RacamierCEO
Investors · 2
Frequently asked questions
- What does EsoCap Biotech do?
- EsoCap is developing a smart drug delivery platform for long-lasting, targeted topical therapy of the esophagus, designed to increase mucosal contact time and drug deposition. Its lead candidate ESO-101 is being developed to treat patients with eosinophilic esophagitis (EoE).
- Who are EsoCap Biotech's investors?
- EsoCap Biotech's investors include CARELA Holding GmbH, sandstorm.vc.